Gastroenterologia
Nature Outlook | Hepatite B.
1 Abr, 2022 | 12:10hPágina principal: Nature Outlook: Hepatitis B
Closing in on a cure for hepatitis B
Developing a cure for chronic hepatitis B requires a fresh approach
How to stop mother-to-child transmission of hepatitis B
Simplify access to hepatitis B care
Facing the challenge of eliminating hepatitis B
The global fight against hepatitis B is benefitting some parts of the world more than others
Africa’s struggle with hepatitis B
Why hepatitis B hits Aboriginal Australians especially hard
Hepatitis B and the liver cancer endgame
Research round-up: hepatitis B
Charting a new frontier in chronic hepatitis B research to improve lives worldwide
Addressing the unmet need for a functional cure for chronic hepatitis B
Revisão sistemática | Eficácia baseada em evidências do metotrexato na doença de Crohn em adultos em diferentes indicações intestinais e extraintestinais.
1 Abr, 2022 | 12:01hDiretriz clínica SEOM | Náusea e vômito induzidos por quimioterapia.
1 Abr, 2022 | 11:56hSEOM clinical guideline emesis (2021) – Clinical and Translational Oncology
Conteúdos relacionados:
Prevention of Chemotherapy-induced nausea and vomiting in the older patient: optimizing outcomes.
Estudo de coorte retrospectiva | Riscos de anafilaxia com formulações intravenosas de ferro.
31 Mar, 2022 | 13:19hRisks for Anaphylaxis With Intravenous Iron Formulations: A Retrospective Cohort Study – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products – Rutgers University
Comentário: Risks for Anaphylaxis Compared Among IV Iron Products – HealthDay
Revisão sistemática | Probióticos para tratamento da constipação crônica em crianças.
31 Mar, 2022 | 13:09hProbiotics for treatment of chronic constipation in children – Cochrane Library
Resumo: Probiotics for treatment of chronic constipation in children – Cochrane Library
Metanálise de estudos randomizados | Agonistas receptores de GLP1 aumentam o risco de doenças de vias biliares e vesícula biliar (RR 1,37; IC 95%, 1,23-1,52).
29 Mar, 2022 | 15:07hAssociation of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials – JAMA Internal Medicine (gratuito por tempo limitado)
Commentary: GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?— Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug – MedPage Today (gratuito por tempo limitado)
Atualização de diretriz de prática clínica da AGA sobre a função da dieta na síndrome do intestino irritável.
29 Mar, 2022 | 14:22hConteúdos relacionados:
10 mistakes in dietary management of irritable bowel syndrome and how to avoid them.
Supplement: Irritable bowel syndrome and related conditions.
RCT: FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome.
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Guidelines for the treatment of irritable bowel syndrome
ACG Clinical Guideline: Management of irritable bowel syndrome
M-A: Efficacy of a low-FODMAP diet in adult irritable bowel syndrome
Revisão | Avaliação de risco cirúrgico em pacientes com doenças hepáticas crônicas.
25 Mar, 2022 | 15:50h
Comentário no Twitter
Surgical Risk Assessment in Patients With Chronic Liver Diseases https://t.co/us01T2XsxE
— Journal of Clinical and Experimental Hepatology (@JCEH_Hepatology) March 23, 2022
Ampla experiência multicêntrica francesa | Síndrome da enterocolite induzida pela proteína alimentar.
25 Mar, 2022 | 15:23hEstudo observacional sugere que antieméticos antidopaminérgicos (domperidona, metopimazina e metoclopramida) estão associados com risco aumentado de AVC.
25 Mar, 2022 | 14:59hComunicado de imprensa: Widely used nausea drugs linked to heightened risk of stroke – BMJ